GlassScriptPhysician profile
Charles J Gatt
NPI 1861497257
$6,759.55
in general payments reported to CMS, 2019-2025
12 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $382 · 2021: $785 · 2022: $1,539 · 2023: $475 · 2024: $1,104 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $1,247 · Travel and Lodging: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $1,247.38 |
| Travel and Lodging | $630.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,554.00 | 2021-2025 | |
| Smith+Nephew, INC. | $1,415.75 | 2019-2024 | Na, Accu-Pass, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Seapearl East, INC | $1,387.81 | 2021-2025 | |
| Avanos Medical | $529.57 | 2020-2024 | On-Q* Pump and Accessories |
| Stryker Corporation | $321.45 | 2020-2024 | Gamma |
| Integra Lifesciences Corporation | $128.32 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $114.33 | 2019-2024 | Velys |
| Acumed LLC | $94.51 | 2019-2020 | |
| Nalu Medical, INC. | $72.98 | 2025 | Nalu Neurostimulation System |
| Miach Orthopaedics, INC. | $72.11 | 2021 | |
| Medline Industries LP | $39.17 | 2023-2024 | |
| Djo, LLC | $29.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.